Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- WOR +10.2%, BB +8.8%, ATEX +4.4%, AVAV +1.4%, WGO +0.5%
Other news:
- QS +34.2% (Cobra separator process enters baseline production)
- LIMN +20% (stock offering by selling shareholders)
- EHTH +5.8% (is continuing its search for a successor chief executive officer; Soistman has agreed to continue serving as chief executive officer in light of the extended search period)
- ECX +5% (secures non-automotive customer for its Lidar Solution)
- MIR +4.7% (partnership with Westinghouse Electric to provide digital ex-core nuclear instrumentation systems)
- ALVO +3.6% (reports top line results from confirmatory efficacy study for proposed biosimilar to Xolair)
- KGEI +3.2% (receives 30% bank line increase; provides operations update)
- VSTM +2.9% (First Patient Dosed with VS-7375)
- AQST +2.5% (to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit)
- JACK +2.2% (names new COO)
- HIVE +2.2% (HIVE Digital Technologies' BUZZ HPC launches another NVIDIA (NVDA) Hopper GPU Cluster in Quebec)
- FINV +1.9% (completes offering of $150 mln convertible senior notes)
- ARRY +1.7% (prices offering of $300 mln of 2.875% convertible senior notes due 2031)
- PSEC +1.3% (CEO bought 623300 shares)
- VKTX +1.3% (initiation of the VANQUISH Phase 3 clinical program for VK2735)
- FOLD +1.1% (announces approval of Pombiliti + Opfolda in Japan)